Establishment of tumor microenvironment-preserving organoid model from patients with intracranial meningioma.

Taken together, our MNO model overcame limitations of previous meningioma models and showed superior resemblance to parental tumors. Thus, our model could facilitate translational research identifying and selecting drugs for meningioma in the era of precision medicine.